Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-negative Breast Cancer × sacituzumab govitecan × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 28 Triple Negative Breast Neoplasms 24 Carcinoma, Transitional Cell 9 Neoplasm Metastasis 8 Carcinoma, Non-Small-Cell Lung 8 Urinary Bladder Neoplasms 7 Lung Neoplasms 5 Endometrial Neoplasms 3 Brain Neoplasms 3 Small Cell Lung Carcinoma 2 Salivary Gland Neoplasms 2 Ovarian Neoplasms 2 Advanced Breast Cancer 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urothelial Bladder Carcinoma 1 Triple Negative Locally Advanced Non-resectable Breast Cancer 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Recurrence 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasm, Residual 1 Mouth Neoplasms 1 Metastatic Urothelial Cancer 1

Interventions

pembrolizumab 1 Paclitaxel 1 Doxorubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡